E-journal of Cardiology Practice: New edition on-line

Category: News
Cardiovascular Risk Reduction by Inhibition of Cholesterol Resorption – a New Therapeutical Strategy? by Dr. Nikos Werner and Prof. Michael Böhm, Nucleus member of the ESC Working Group on Heart Failure, Homburg-Saar, Germany. "Hyperlipidemia is an important cardiovascular risk factor. Reaching LDL target concentrations is difficult even with a statin. Ezetimibe effectively lowers LDL in familiar hypercholesterolemia and refractory primary hypercholesterolemia." Read the full text here...